Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)
- PMID: 16626829
- DOI: 10.1016/j.radonc.2006.03.012
Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)
Abstract
Background and purpose: To define the dose-response relationship of nasopharyngeal carcinoma (NPC) above the conventional tumoricidal dose level of 66 Gy when the basic radiotherapy (RT) course was given by the 2D Ho's technique.
Patients and methods: Data from all five regional cancer centers in Hong Kong were pooled for this retrospective study. All patients (n = 2426) were treated with curative-intent RT with or without chemotherapy between 1996 and 2000 with the basic RT course using the Ho's technique. The primary endpoint was local control. The prognostic significance of dose-escalation ('boost') after 66 Gy, T-stage, N-stage, use of chemotherapy, sex and age (< or =40 years vs >40 years) was studied. Both univariate and multivariate analyses were performed.
Results: On multivariate analysis, T-stage (P < 0.01; hazard ratio [HR], 1.58) and optimal boost (P = 0.01; HR, 0.34) were the only significant factors affecting local failure for the whole study population, and for the population of patients treated by radiotherapy alone, but not for patients who also received chemotherapy. The following were independent determinants of local failure for patient groups with different T-stages treated by radiotherapy alone: use of a boost in T1/T2a disease (P = 0.01; HR, 0.33); use of a boost (P < 0.01; HR, 0.60) and age (P = 0.01; HR, 1.02) in T3/T4 tumors. Among patients with T2b tumors treated by radiotherapy alone and given a boost, the use of a 20 Gy-boost gave a lower local failure rate than a 10 Gy-boost. There was no apparent excess mortality attributed to RT complications.
Conclusions: Within the context of a multi-center retrospective study, dose-escalation above 66 Gy significantly improved local control for T1/T2a and T3/4 tumors when the primary RT course was based on the 2D Ho's technique without additional chemotherapy. 'Boosting' in NPC warrants further investigation. Caution should be taken when boosting is considered because of possible increase in radiation toxicity.
Similar articles
-
Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.Head Neck. 2005 May;27(5):397-405. doi: 10.1002/hed.20161. Head Neck. 2005. PMID: 15726589
-
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1440-50. doi: 10.1016/j.ijrobp.2004.05.022. Int J Radiat Oncol Biol Phys. 2004. PMID: 15590175
-
Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.Head Neck. 2004 May;26(5):389-95. doi: 10.1002/hed.10398. Head Neck. 2004. PMID: 15122654 Clinical Trial.
-
A multi-institutional survey of the effectiveness of chemotherapy combined with radiotherapy for patients with nasopharyngeal carcinoma.Jpn J Clin Oncol. 2004 Oct;34(10):569-83. doi: 10.1093/jjco/hyh111. Jpn J Clin Oncol. 2004. PMID: 15591454 Review.
-
Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma.Cancer. 2005 Jan 1;103(1):22-31. doi: 10.1002/cncr.20768. Cancer. 2005. PMID: 15565580 Review.
Cited by
-
Concurrent chemoradiotherapy for T3-4 and N0-1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia.J Radiat Res. 2016 Jan;57(1):44-9. doi: 10.1093/jrr/rrv046. Epub 2015 Aug 8. J Radiat Res. 2016. PMID: 26254458 Free PMC article.
-
PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.Radiat Oncol. 2017 Jan 13;12(1):15. doi: 10.1186/s13014-016-0739-y. Radiat Oncol. 2017. PMID: 28587681 Free PMC article.
-
Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma.Radiat Oncol. 2013 Jun 27;8:157. doi: 10.1186/1748-717X-8-157. Radiat Oncol. 2013. PMID: 23806065 Free PMC article. Clinical Trial.
-
Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.Radiat Oncol. 2014 Mar 27;9:87. doi: 10.1186/1748-717X-9-87. Radiat Oncol. 2014. PMID: 24674015 Free PMC article.
-
Developing an adaptive radiation therapy strategy for nasopharyngeal carcinoma.J Radiat Res. 2014 Mar 1;55(2):293-304. doi: 10.1093/jrr/rrt103. Epub 2013 Aug 29. J Radiat Res. 2014. PMID: 23988444 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources